Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors

por Shah, Manisha H., Lorigan, Paul, O’Brien, Mary E. R., Fossella, Frank V., Moore, Kathleen N., Bhatia, Shailender, Kirby, Maurice, Woll, Penella J.
Publicado 2016

A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in pati...

por Minchom, Anna, Mak, Daisy, Gunapala, Ranga, Walder, David, Kumar, Rajiv, Yousaf, Nadia, Hodgkiss, Andrew, Bhosle, Jaishree, Popat, Sanjay, O’Brien, Mary E. R.
Publicado 2019

A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments

por Minchom, Anna, Thavasu, Parames, Ahmad, Zai, Stewart, Adam, Georgiou, Alexandros, O’Brien, Mary E. R., Popat, Sanjay, Bhosle, Jaishree, Yap, Timothy A., de Bono, Johann, Banerji, Udai
Publicado 2017

A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors

por O’Brien, Mary E. R., Sarker, Debashis, Bhosle, Jaishree, Thillai, Kiruthikah, Yap, Timothy A., Uttenreuther-Fischer, Martina, Pemberton, Karine, Jin, Xidong, Wiebe, Sabrina, de Bono, Johann, Spicer, James
Publicado 2018

Evaluation of diffusion-weighted MRI and (18F) fluorothymidine-PET biomarkers for early response assessment in patients with operable non-small cell lung cancer treated with neoadj...

por Carlin, Dominic, Weller, Alexander, Kramer, Gem, Liu, Yan, Waterton, John C, Chiti, Arturo, Sollini, Martina, Joop de Langen, A, O’Brien, Mary E R, Urbanowicz, Maria, Jacobs, Bart KM, deSouza, Nandita
Publicado 2019